William P Sheridan - Net Worth and Insider Trading

William P Sheridan Net Worth

The estimated net worth of William P Sheridan is at least $296,800 dollars as of 2024-11-13. William P Sheridan is the Chief Medical Officer of BioCryst Pharmaceuticals Inc and owns about 37,954 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $296,800. Details can be seen in William P Sheridan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William P Sheridan has not made any transactions after 2022-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of William P Sheridan

To

William P Sheridan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, William P Sheridan owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of William P Sheridan’s form 4 insider trades.

Insider Ownership Summary of William P Sheridan

Ticker Comapny Transaction Date Type of Owner
BCRX BioCryst Pharmaceuticals Inc 2022-03-10 SR VP - CMO

William P Sheridan Latest Holdings Summary

William P Sheridan currently owns a total of 1 stock. William P Sheridan owns 37,954 shares of BioCryst Pharmaceuticals Inc (BCRX) as of March 10, 2022, with a value of $296,800.

Latest Holdings of William P Sheridan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2022-03-10 37,954 7.82 296,800

Holding Weightings of William P Sheridan


William P Sheridan Form 4 Trading Tracker

According to the SEC Form 4 filings, William P Sheridan has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 161,139 shares on March 10, 2022, which brought William P Sheridan around $3 Million.

Insider Trading History of William P Sheridan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

William P Sheridan Trading Performance

GuruFocus tracks the stock performance after each of William P Sheridan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William P Sheridan is 108.42%. GuruFocus also compares William P Sheridan's trading performance to market benchmark return within the same time period. The performance of stocks bought by William P Sheridan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how William P Sheridan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of William P Sheridan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -36.84 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -21.7 LIMIT LIMIT LIMIT LIMIT LIMIT

William P Sheridan Ownership Network

Ownership Network List of William P Sheridan

No Data

Ownership Network Relation of William P Sheridan

Insider Network Chart

William P Sheridan Owned Company Details

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

William P Sheridan is the SR VP - CMO of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, William P Sheridan made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

William P Sheridan Mailing Address

Above is the net worth, insider trading, and ownership report for William P Sheridan. You might contact William P Sheridan via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.